![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention in Women
|
|
|
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
Jared M. Baeten1; Thesla Palanee-Phillips2; Elizabeth R. Brown3; Katie Schwartz4; Lydia E. Soto-Torres5; Annalene Nel6; Zeda Rosenberg7; Ian McGowan8; Sharon L. Hillier9; for the MTN-020/ASPIRE Study Team
1Univ of Washington, Seattle, WA, USA; 2Wits Reproductive Hlth and HIV Inst, Johannesburg, South Africa; 3Statistical Cntr for HIV/AIDS Rsr & Prevention, Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 4FHI 360, Durham, NC, USA; 5NIAID, NIH, Bethesda, MD, USA; 6Intl Partnership for Microbicides, Paarl, South Africa; 7International Partnership for Microbicides, Silver Spring, MD, USA; 8Univ of Pittsburgh Sch of Med, Pittsburgh, PA, USA; 9Magee-Womens Hosp of the Univ of Pittsburgh Med Cntr, Pittsburgh, PA, USA
WEBCAST link: http://www.croiwebcasts.org/console/player/29584?mediaType=audio&
![CROI1](../images/022916/022916-6/CROI1.gif)
![CROI2](../images/022916/022916-6/CROI2.gif)
![CROI3](../images/022916/022916-6/CROI3.gif)
![CROI4](../images/022916/022916-6/CROI4.gif)
![CROI5](../images/022916/022916-6/CROI5.gif)
![CROI6](../images/022916/022916-6/CROI6.gif)
![CROI7](../images/022916/022916-6/CROI7.gif)
![CROI8](../images/022916/022916-6/CROI8.gif)
![CROI9](../images/022916/022916-6/CROI9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|